Stay updated on Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page.

Latest updates to the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe recruitment status is updated to 'No longer looking for participants', indicating enrollment is closed for the study. The revision history shows the record updated to 'Revision: v3.6.0' from the previous 'Revision: v3.5.5'.SummaryDifference0.1%

- Check20 days agoChange DetectedThe revision history now includes a new revision tag v3.5.5. The previous tag v3.5.4 has been removed, updating the page's version history to reflect a minor maintenance change rather than any study data update.SummaryDifference0.0%

- Check41 days agoChange DetectedThe history shows a new revision (v3.5.4) dated 2026-05-13 that adds several core study sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow, Arms and Interventions, Study Design, Study Status) and related document/contacts sections, while the previous revision (v3.5.3) dated 2025-10-14 is removed.SummaryDifference0.5%

- Check62 days agoChange DetectedA site revision/version indicator was updated from v3.5.2 to v3.5.3 on the record history page, reflecting a platform update rather than a change to the trial information.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a minor technical update to the page history.SummaryDifference0.0%

- Check98 days agoChange DetectedRevision v3.5.0 was added to the history and Revision v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mirikizumab Maintenance Study in Ulcerative Colitis Clinical Trial page.